0001193125-09-100028 Sample Contracts

CONFIDENTIAL PROVISIONS REDACTED ASSET PURCHASE AGREEMENT BY AND BETWEEN PDL BIOPHARMA, INC., a Delaware corporation and EKR THERAPEUTICS, INC., a Delaware corporation Dated as of February 4, 2008

Asset Purchase Agreement • May 5th, 2009 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Asset Purchase Agreement
• Filed
  May 5th, 2009
• Company
  PDL Biopharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

* Certain information on this page has been omitted and filed separately with the SEC. Confidential treatment has been requested with respect to the omitted portions.

CONFIDENTIAL PROVISIONS REDACTED ASSET PURCHASE AGREEMENT BY AND BETWEEN PDL BIOPHARMA, INC., a Delaware corporation and GMN, INC., a Delaware corporation Dated as of February 21, 2008

Asset Purchase Agreement • May 5th, 2009 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • Minnesota

• Contract Type
  Asset Purchase Agreement
• Filed
  May 5th, 2009
• Company
  PDL Biopharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Minnesota

This Asset Purchase Agreement (this “Agreement”) is entered into as of February 21, 2008 (the “Effective Date”) between PDL BioPharma, Inc., a Delaware corporation (“Seller”), and GMN, Inc., a Delaware corporation (“Buyer”), a wholly owned subsidiary of Genmab A/S, a corporation existing under the laws of Denmark.